Tissue Sampling and Biorepository to improve Cancer Cell Therapy
Demographics (2)
- AGE - Subject age at time of treatment (phv00525831.v1.p1)
- SEX - Biological sex (phv00525825.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00525830.v1.p1)
Other (19)
- AFFECTION_STATUS - Case control status of the subject for lymphoma; all subjects are lymphoma patients. (phv00525829.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00525840.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00525839.v1.p1)
- COHORT - Cohort subject included in (phv00525832.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00525824.v1.p1)
- DAY - Day sample collected relative to CAR T-cell infusion (phv00525843.v1.p1)
- DEATH - Patient death following treatment (phv00525834.v1.p1)
- EVENT - Presence of event following treatment (phv00525833.v1.p1)
- EVENT_FREE_SURVIVAL - Event free survival following treatment (phv00525835.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00525842.v1.p1)
- HISTOLOGY - Large B-cell Lymphoma Subtype (phv00525837.v1.p1)
- IS_TUMOR - Tumor status (phv00525841.v1.p1)
- OVERALL_SURVIVAL - Overall survival following treatment (phv00525836.v1.p1)
- SAMPLE_ID - Sample ID (phv00525838.v1.p1)
- SAMPLE_ID - Sample ID (phv00525827.v1.p1)
- SUBJECT_ID - Subject ID (phv00525828.v1.p1)
- SUBJECT_ID - Subject ID (phv00525823.v1.p1)
- SUBJECT_ID - Subject ID (phv00525826.v1.p1)
- TUMOR_CATEGORY - Tumor category either relapse or pretreatment (phv00525844.v1.p1)